September 14, 2010
Multiple sclerosis patients who have albuterol, a medication used to treatasthma and some respiratory diseases, added to their treatment appear to benefit with improved clinical outcomes, say researchers in an article published in Archives of Neurology.
Multiple sclerosis is a long-term (chronic) inflammatory disease in which the myelin – the coating of nerve cells in the white matter of the CNS (central nervous system) – degenerates. Multiple sclerosis patients have high levels of inteleukin-12, a compound that encourages the generation of a type of helper T cell linked to myelin degeneration.
Click here to continue
Disclaimer: ‘MS Views and News’ (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.